Cytokinetics CYTK has outperformed the market over the past 5 years by 46.76% on an annualized basis producing an average annual return of 59.6%. Currently, Cytokinetics has a market capitalization of $7.70 billion.
Buying $1000 In CYTK: If an investor had bought $1000 of CYTK stock 5 years ago, it would be worth $10,649.92 today based on a price of $78.49 for CYTK at the time of writing.
Cytokinetics's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.